✨ Your Portfolio is fetched and updated from zerodha.
Small Hospitals
Market Cap
₹9,829 Cr.
P/E
50.69
About
Jupiter Life Line Hospitals Limited operates hospitals and clinics in India, offering multi-specialty tertiary and quaternary healthcare services. Starting in 2007 in Thane, Maharashtra, the company e… Read more
Jupiter Life Line Hospitals Limited operates hospitals and clinics in India, offering multi-sp… Read more
Low
1068
52W Range
High
1770
  • Jupiter Life Line
  • HealthcareGlobal
  • Kovai Medical Center
  • TJI Hospitals

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

8 Yes

Positive for this company

2 Neutral

Neutral for this company

6 No

Negative for this company

1 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Customer Segment

Operational Metrics

    Select a Metric
    • Average Daily Revenue Per Occupied Bed (Rs)
    • Hospital Occupancy Rate (%)
    • Average Length Of Stay (Days)
    • Operational Beds (.)
    • Number of Outpatient Visits - Quarterly (.)
    Peer Comparison
    Corporate Actions
    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less
    FAQs on Jupiter Life Line Hospitals Ltd. Business

    Jupiter Life Line Hospitals Limited operates and manages hospitals and clinics in India. It is a leading multi-specialty healthcare provider with hospitals in Maharashtra and Madhya Pradesh, offering services in densely populated areas with low presence of chained hospitals.

    Jupiter Life Line major competitors are HealthcareGlobal, Kovai Medical Center, RainbowChildrenS Med, Yatharth Hospital, Artemis Medicare, Indraprastha Medical, Shalby.
    Market Cap of Jupiter Life Line is ₹9,829 Crs.
    While the median market cap of its peers are ₹4,907 Crs.

    Jupiter Life Line seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    Company Filing
    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release
    Investor Presentation Mar Jun Sep Dec Jun Sep Dec
    Conference Call Mar Jun Sep Dec Sep Dec
    Conference Call SummaryCon Call Summary
    Discussions & Analysis
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material